Monday, May 15, 2023

US investor Janus Henderson cut PharmEasy valuation by half to $2.8 billion

The global investor, which picked a stake in PharmEasy in September 2021, has reduced the valuation of its holding in the firm by half, which would translate to an approximate valuation of around $2.8 billion as of December 31, 2022.

from Tech-Economic Times https://ift.tt/cKLOgj7
at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

Softbank Group launches over $10 billion in bonds for OpenAI investment, term sheet shows

The dollar-denominated notes are split into 3-1/2-year, 5-1/2-year and 7-1/2-year tenors, while the euro-denominated bonds are split into 4-...